Harvard Apparatus Regenerative Technology, Inc.

Industry

  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Pharmaceuticals
  • Digital Health
    • Disease Management

Other Names/Subsidiaries

  • Biostage
See more in Biomedtracker

Latest on Harvard Apparatus Regenerative Technology, Inc.

In Vivo

Deals Shaping The Medical Industry, March 2017

 
• By Steven Muntner, Beth Allan, Deanna Kamienski, Amanda Micklus, and Maureen Riordan

IN VITRO DIAGNOSTICS Financings Vermillion Inc. Vermillion Inc. grossed $5.6mm through the private sale of 3.75mm common shares at $1.40 (a 6% premium). Investors also received five-year warrants

Medtech Insight

Medical Device Deals Update, June 2016

In Vivo

Deals Shaping The Medical Industry, June 2016

IN VITRO DIAGNOSTICS Mergers & Acquisitions Luminex Corp. Nanosphere Inc. Luminex Corp. is paying $77mm ($1.70 per share; a 63% premium) in cash to acquire molecular diagnostics firm Nanosphere

Medtech Insight

Medical Device Deals Update, January 2016